跳至主要内容
临床试验/NCT04069078
NCT04069078已完成4 期

Prophylactic Use of Iv Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section Under Spinal Anaesthesia. a Randomized Controlled Trial

Assiut University1 个研究点 分布在 1 个国家目标入组 173 人开始时间: 2019年10月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
173
试验地点
1
主要终点
Bradycardia

研究概览

简要总结

The aim of this study is to assess the efficacy of Iv hyoscine butylbromide in preventing Bradycardia during cesarean section under spinal anaesthesia with local anaesthetic and morphine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA physical status class I-II.
  • Age: 18 Years to 40 Years.
  • Women scheduled for elective Cesarean section under spinal anesthesia.
  • indications for CS other than fetal or maternal pathology.

排除标准

  • Height < 150 or > 180 cm
  • Body mass index (BMI) >35 kg/m2
  • Contraindication for central neuraxial block
  • Refusal to undergo regional anesthesia
  • Known allergy to any of the study drugs,
  • Infection at the site of injection,
  • Coagulopathy,
  • Indication to general anesthesia
  • Baseline bradycardia (heart rate < 60/min), or any cardiovascular disease
  • Patients taking β-adrenergic blockers or any drugs that may alter normal response to study drugs.
  • Arrhythmia such as atrial fibrillation, supraventricular tachycardia, heart block greater than first degree, left bundle branch block,
  • Hypertension (systolic blood pressure more than 140 mm Hg or diastolic blood pressure more than 90 mm Hg), unstable angina or cardiomyopathy,
  • Associated medical problem with pregnancy (as hypertension, diabetes mellitus, hepatic impairment or renal impairment)

研究组 & 干预措施

Hyoscine butylbromide

Active Comparator

干预措施: Hyoscine Butylbromide 20 Mg/mL Solution for Injection Ampoule (Drug)

Control

Placebo Comparator

干预措施: Normal saline (Other)

结局指标

主要结局

Bradycardia

时间窗: intraoperative

number of participants who will develop heart rate below 50 BPM.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mostafa Samy Abbas

associate professor of anesthesia

Assiut University

研究点 (1)

Loading locations...

相似试验